the present invention provides individual crystalline polymorphs of 7 -- 3 -- 6 - methoxy )- triazolopyridazine designated form 5 . the form 5 polymorph disclosed herein is characterized according to one or more of powder x - ray diffraction data ; differential scanning calorimetry ; ft - raman spectroscopy ; ft - ir spectroscopy ; and thermogravimetric analysis .